Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-center clinical study of refractory syphilis for standardized diagnosis and treatment
ChiCTR2000037071Phase 4Not yet recruiting
- Sponsor
- Shanghai Skin Disease Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Benzathine penicillin, doxycycline and ceftriaxone in syphilis and neurosyphilis (3 arms), sponsored by Shanghai Skin Disease Hospital. Primary endpoints: Clinical symptoms and Laboratory indicators. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
Benzathine penicillindoxycyclineceftriaxone
03
Conditions
syphilisneurosyphilis
Beyond the preview
Go deeper on ChiCTR2000037071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037071.